Axio Bio is a medical technology company that has developed proprietary hemostat products to immediately stop bleeding in heavy wounds. It has also developed advanced wound care products for patients suffering from chronic wounds. It is the first global wound care brand from India and sells its products to over 50 countries. It is headquartered in the US with its manufacturing and R&D operations based out of India. The company has built a strong R&D portfolio, with multiple global patents in wound healing, surgical wounds and hemostats to its credit. For more information, please visit https://axiobio.com